Influenza neuraminidase tetramers
AssigneeIcosavax, Inc.
InventorDaniel ELLIS
Life of this patent
Estimating the term…
Loading patent…
AssigneeIcosavax, Inc.
InventorDaniel ELLIS
Estimating the term…
The disclosure relates to compositions that include a recombinant influenza neuraminidase tetramer that includes four copies of a fusion protein which includes a DA4B tetramerization domain, optionally a linker, and an influenza NA head domain, and uses thereof. Novel linkers are provided. The disclosure further relates to a recombinant influenza neuraminidase (NA) polypeptide, comprising an influenza NA head domain comprising one or more amino acid substitutions selected from the group consisting of I99P, Y100L, T131Q, C161V, E165S, S172A, V177I, S196T, V205I, Q408M, R419V, and V453T. Further provided are compositions, methods of making, and methods of use, for example as vaccines for influenza.
A recombinant influenza neuraminidase (NA) tetramer, comprising four copies of a fusion protein, said fusion protein comprising, in N- to C-terminal order, a DA4B tetramerization domain and an influenza NA head domain,
-9. (canceled)
-13. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
-29. (canceled)
-33. (canceled)
A recombinant influenza neuraminidase (NA) polypeptide, comprising an influenza NA head domain comprising one or more amino acid substitutions selected from the group consisting of I99P, Y100L, T131Q, C161V, E165S, S172A, V177I, S196T, V205I, Q408M, R419V, and V453T, numbered relative SEQ ID NO:
-53. (canceled)
(canceled)
(canceled)
-63. (canceled)
-69. (canceled)
-73. (canceled)
A protein nanostructure comprising a trimeric component comprising a trimer polypeptide and a pentameric component comprising a pentamer polypeptide, wherein the trimer polypeptide is a fusion protein comprising, in N- to C-terminal order, an influenza HA ectodomain, a polypeptide linker, and an assembly domain,
-81. (canceled)
Dependencies are inferred from the claim text.